Skip to main content

Advertisement

Table 6 Effect of duration of Diabetes on the prevalence of microangiopathies in study population with or without Metabolic Syndrome

From: Prevalence of Metabolic Syndrome and its influence on microvascular complications in the Indian population with Type 2 Diabetes Mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 14)

   Prevalence of Microangiopathy  
Variables Groups Duration (0-10 years) p Duration (11-20 years) p Duration (> 20 years) p
Overall        
Retinopathy MS Absent 48 (28.2) < 0.0001 25 (34.7) 0.013 6 (46.2) 1.000
  MS Present 122 (71.8)   47 (65.3)   7 (53.8)  
Nephropathy MS Absent 61 (29.6) < 0.0001 12 (22.6) < 0.0001 3 (60.0) 1.000
  MS Present 145 (70.4)   41 (77.4)   2 (40.0)  
Neuropathy MS Absent 38 (19.9) < 0.0001 18 (31.0) 0.005 7 (46.7) 1.000
  MS Present 153 (80.1)   40 (69.0)   8 (53.3)  
Men        
Retinopathy MS Absent 36 (34.3) 0.002 19 (43.2) 0.451 6 (66.7) 0.508
  MS Present 69 (65.7)   25 (56.8)   3 (33.3)  
Nephropathy MS Absent 46 (43.4) 0.206 11 (36.7) 0.200 3 (60.0) 1.000
  MS Present 60 (56.6)   19 (63.3)   2 (40.0)  
Neuropathy MS Absent 24 (24.2) < 0.0001 16 (40.0) 0.268 6 (60.0) 0.754
  MS Present 75 (75.8)   24 (60.0)   4 (40.0)  
Women        
Retinopathy MS Absent 12 (18.5) < 0.0001 6 (21.4) 0.004 0 (0.0) 0.125
  MS Present 53 (81.5)   22 (78.6)   4 (100.0)  
Nephropathy MS Absent 15 (15.0) < 0.0001 1 (4.3) < 0.0001 0 (0.0) NA
  MS Present 85 (85.0)   22 (95.7)   0 (0.0)  
Neuropathy MS Absent 14 (15.2) < 0.0001 2 (11.1) 0.001 1 (20.0) 0.375
  MS Present 78 (84.8)   16 (88.9)   4 (80.0)  
  1. MS, Metabolic Syndrome